Select Page

Why Mimosa?

The Mimosa tenuiflora tree is a symbol of ancient regenerative healing. In the 10th century, the Mayans were already utilizing its bark for its incredible capability to heal wounds. Today we have discovered that its roots also contains one of the highest levels of DMT from any botanical known to man. At MIMOSA, we aim to bring the healing power of entheogens such as the Mimosa tenuiflora tree back into service for greater good of humanity.

  

Origin Story

James Keim, Amanda Feilding, Bob Stanley, and other major figures in the psychedelic world shared a similar vision; they wanted to create an international company that would produce high-quality, natural entheogensDefinition: “becoming divine within” // chemical substance, typically of plant origin, that is ingested to produce a nonordinary state of consciousness for religious or spiritual purposes. at very affordable prices. Informed by ethical capitalism and grounded in morals and practices of the psychedelic community, Mimosa Therapeutics was formed as a Public Benefit Corporation.

Mission

To help people access the best, healthiest version of themselves through the careful and intentional use of entheogens.

Our Offerings Are

Safe
Uniform.
Consistent.
Sacred.
Inclusive.
Organic.

Our Commitments as a Public Benefit Corporation

A Team With Deep Roots

Leading Figures from the World of Psychedelics

Amanda Feilding

Co-founder, Director

The founder of the Beckley Foundation and one of the best-known and respected figures in the world of psychedelic research and drug policy.

James Keim

Co-founder, CEO

Previously served as CEO of OLP Therapeutics and other startups. He is also a psychedelic therapist, Fulbright Specialist, and co-author of the book, The Violence of Men.

Tyra Callaway

Vice President, Formulations

Tyra has years of industrial experience in the development and scale up of formulation, synthesis, and extraction processes to pilot and production scales, including the development of formulations for hundreds of commercialized products encompassing natural supplements, skincare, cosmetics, and entheogen preparations.

Bob Stanley

Chief Sacrament Officer
Senior Vice President

Bob Stanley is the Chief Garden Steward for Sacred Garden Community Church, was the co-founder of two previous life science informatics companies and was the founding chair of Decriminalize Nature, Oakland.

Jon Cassel

Chief Operating Officer

Jon is a seasoned operational and technology development executive with over 30 years of experience creating the operational capabilities needed to rapidly scale and robustly provide new leading-edge products and services globally.

Antoni Gandia

Vice President for Bioreactor Production

Antoni has deep expertise and extensive experience in fungal biomass production from his previous academic and industrial work at Ecovative Design and Mogu. Antoni has authored over 20 scientific publications and patents in fungal biotechnology.

Felix Blei

Vice President for Analytics

Felix is one of the leading scientists of psychedelic mushrooms whose research laid the foundation for our understanding of them. He helped characterize and elucidate the biosynthesis of psilocybin and is also the discoverer of beta-carbolines in Psilocybe. 

 

John Turner

Senior Advisor

John served for 17 years as a corporate attorney at Wilson Sonsini, Silicon Valley’s leading law firm. John is a senior adviser at the Alexander Shulgin Research Institute and founded Trippingly.net, a pioneering source of reliable information on psychedelics.

Jonathan Keim

Creative Director

After launching Indonesia’s first vegan gelato brand and two world-renowned life coach training schools, Jonathan Keim started working as a Brand Strategist and Creative Director for impact-based businesses.

Andre Humphrey

Director of Training and Access

Andre Humphrey served as founder and executive director of a non-profit dedicated to improving the mental health of black and brown communities. He is also a licensed trauma-informed yoga and meditation facilitator with expertise in holding space for people during difficult times.

Alan Rockefeller

Chief Mycologist

Alan Rockefeller is an Oakland based mycologist who has been studying mushrooms since 2001.  He has now photographed more than 2,500 species of fungi. Alan enjoys mushroom identification, DNA barcoding, mushroom photography and fungal microscopy.

Jake Houbiers

Brand Strategist

Jake has extensive expertise in creating design & activation strategies to reach niche audiences and inspiring them with meaningful and positive change. He is also the founder of Dutch design agency Ministry of MEDIA and holds a teaching position at the University of Utrecht.

Investors

Integrated is a venture fund partnering with value-aligned companies and entrepreneurs that are transforming the health and well-being of our communities around the globe.

They are on a mission to redefine healthcare through the advancement of medicines and the integration of transformative therapies.

MIMOSA is a team of world renowned experts utilizing cutting edge science, technology, testing and production methods to make consistent, measurable, medical-grade natural entheogens available to the market at affordable prices.

Contact

Info@mimosatherapeutics.com